What is Brevium?
Brevium operates at the intersection of healthcare informatics and automated patient engagement. The company provides a sophisticated software platform that integrates directly with existing practice management systems to identify, contact, and reactivate patients who have fallen out of the care cycle. By automating the outreach process, Brevium enables medical practices to optimize their appointment schedules, improve clinical compliance, and drive sustainable revenue growth. The platform is engineered to support a wide array of medical specialties, offering customizable communication workflows and robust reporting analytics that provide actionable insights into practice performance and patient health outcomes.
How much funding has Brevium raised?
Brevium has raised a total of $1.4M across 2 funding rounds:
Debt
$350K
Stock/Share Issuance
$1M
Debt (2020): $350K with participation from PPP
Stock/Share Issuance (2025): $1M, investors not publicly disclosed
Key Investors in Brevium
Undisclosed Investor
An institutional participant providing capital to support the company's strategic growth initiatives.
PPP
Public-Private Partnership
What's next for Brevium?
With the recent influx of capital, Brevium is expected to scale its operations to meet the growing demand for automated patient management solutions. The strategic roadmap likely includes expanding the platform's integration capabilities with a broader range of electronic health record systems and enhancing its predictive analytics engine to better identify at-risk patient populations. As the healthcare industry continues to prioritize patient-centric care and operational efficiency, Brevium's focus on closing the gap in the patient journey positions it as a critical partner for practices seeking to maximize their clinical and financial potential in an increasingly competitive landscape.
See full Brevium company page
